Understanding Somatic Evolution: How Our Normal Tissues Change Over Time As a physician, I often discuss how cancer develops from genetic mutations. However, recent research is shifting our perspective, revealing …
Tag:
Oncology
-
-
Vitamin C and Cancer Treatment: What the Latest Research Reveals High-dose vitamin C has long been a topic of debate in cancer treatment. While some tout it as a potential …
-
mRNA Cancer Vaccines: The Next Frontier in Oncology For many, mRNA technology became a household term during the COVID-19 pandemic. However, the application of this technology extends far beyond infectious …
-
Global Coalition Launches Initiative to Strengthen Independent Academic Cancer Trials A new global initiative is calling for greater support and collaboration to ensure independent academic clinical cancer trials continue to …
-
Revolutionary Cord Blood Transplant Approach Achieves 96% Survival Rate in Blood Disease Patients A groundbreaking advancement in hematopoietic stem cell transplantation is transforming treatment outcomes for patients with blood cancers …
-
Teen Attitudes Toward Sun Protection Impact Skin Cancer Prevention Behaviors Understanding how adolescents and young adults perceive sun protection is critical for shaping effective skin cancer prevention strategies. Research shows …
-
Exercise and Ibuprofen May Help Reduce Cognitive Impairment During Chemotherapy A new Phase II clinical trial has found that both exercise and low-dose ibuprofen can help lessen cognitive problems in …
-
Precision Immunotherapy: How Protein Analysis and Degradation are Transforming Cancer Care Immunotherapy has revolutionized the treatment of various cancers, yet its success isn’t universal. The challenge for modern oncology is …
-
Managing Radiotherapy-Induced Oral Mucositis with Photobiomodulation For patients undergoing radiotherapy for head and neck cancers, oral mucositis (OM) is a frequent and debilitating side effect. This condition manifests as painful, …
-
FDA Approves Relacorilant Combination Therapy for Platinum-Resistant Ovarian Cancer On March 25, 2026, the Food and Drug Administration (FDA) approved relacorilant (Lifyorli, Corcept Therapeutics Inc.), a first-in-class selective glucocorticoid receptor …
Newer Posts